Treatment and outcome of 2904 CML patients from the EUTOSpopulation-based registry
Verena Hoffmann(Zimmer Biomet (Germany)), R. Hehlmann(Heidelberg University), Martin Höglund(Uppsala University), Susanne Saußele(University of Mannheim), Andrija Bogdanović(University of Belgrade), Zuzana Sninská(University Hospital Bratislava), Luis Felipe Casado(Complejo Hospitalario Universitario de Toledo), Fausto Castagnetti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Perttu Koskenvesa(Helsinki University Hospital), Francesco Di Raimondo(University of Catania), Paul Costeas(Deakin University), H. Everaus, Andreas Hochhaus(Jena University Hospital), Richard M. Clark(University of Utah), G. Schubert-Fritschle(Ludwig-Maximilians-Universität München), Michele Baccarani(University of Bologna), Sandra Lejniece(Riga East University Hospital), J Guilhot, Andrey Zaritskey, T. Sacha, Karel Indrák(Palacký University Olomouc), Daniela Žáčková(Masaryk University), Laimonas Griškevičius(Vilnius University), Dubravka Sertić(University Hospital Centre Zagreb), Joerg Hasford(Ludwig-Maximilians-Universität München), Doris Lindoerfer(Zimmer Biomet (Germany)), Irena Zupan(Ljubljana University Medical Centre), GJ Ossenkoppele, G. Rosti, Andrzej Hellmann(Gdańsk Medical University), Sonja Burgstaller(Klinikum Wels-Grieskirchen), Bengt Simonsson(Uppsala University Hospital), Anna Turkina(National Medical Research Center for Hematology)
Leukemia
January 1, 2017
Cited by 0
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k